Dr. Catherine Njue is the manager for the Office of Biostatistics in the Biologic and Radiopharmaceutical Drugs Directorate (BRDD), Health Canada. In this position, she leads the biostatistics team that is primarily involved in evaluating the statistical methodology of clinical trials and other sources of evidence for biologics (e.g., vaccines, blood products) and related biotechnology products and radiopharmaceuticals. She also provides statistical expertise in the drafting, review and implementation of standards and guidelines developed by Health Canada, ICH, and WHO working groups.

Dr. Njue received her Ph.D. in Statistics from the University of Manitoba in Winnipeg, Manitoba, Canada. After two years as a Biostatistician at CancerCare Manitoba, she joined Health Canada where she remains. Dr. Njue has extensive experience as a statistical consultant, which began at the Statistical Advisory Service, University of Manitoba, where she worked throughout her doctoral program. At CancerCare Manitoba, she collaborated with researchers in the Department of Preventive Oncology and Epidemiology on the design and analysis of epidemiological studies. She also provided statistical consultation to researchers from various other departments within CancerCare Manitoba.